Michael Wondrasch is the Chief Technology & Data Officer at Kenvue Inc., the world's largest pure-play consumer health company by revenue, where he spearheads the enterprise's technology vision, data strategy, digital transformation, cybersecurity, and innovation initiatives. Reporting directly to the CEO, Wondrasch oversees a global team that powers Kenvue's portfolio of trusted brands, including Tylenol, Neutrogena, Listerine, and Band-Aid, by leveraging cutting-edge AI, cloud computing, and advanced analytics to drive consumer-centric growth and operational excellence. With over 20 years of leadership in technology and data across Fortune 500 companies, Wondrasch's career began at McKinsey & Company, followed by pivotal roles at Procter & Gamble and Unilever. At Unilever, as Vice President of Data Science & Advanced Analytics, he built scalable AI platforms that optimized supply chains and personalized marketing for billions of consumers. Prior to Kenvue's 2023 spin-off from Johnson & Johnson, he served as Global Head of Data & Analytics for J&J's Consumer Health division, where he orchestrated a multi-billion-dollar digital overhaul, integrating data lakes and machine learning to accelerate product development and enhance supply chain resilience. Under Wondrasch's stewardship at Kenvue, the company has achieved landmark milestones, including the rapid deployment of generative AI tools for R&D and customer insights, a 30% improvement in data-driven decision-making speed, and robust cybersecurity frameworks amid evolving threats. His strategic foresight has positioned Kenvue as a leader in health tech innovation, earning him recognition from industry forums like Gartner and Forbes for pioneering ethical AI adoption in consumer health.